BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11162326)

  • 21. Women's views of optimal risk communication and decision making in general practice consultations about the menopause and hormone replacement therapy.
    Walter FM; Emery JD; Rogers M; Britten N
    Patient Educ Couns; 2004 May; 53(2):121-8. PubMed ID: 15140450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patterns and correlates of hormone replacement therapy use among middle-aged Australian women.
    France K; Schofield MJ; Lee C
    Womens Health; 1997; 3(2):121-38. PubMed ID: 9332154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hormone therapy for the management of the menopause in Ecuador: perception, use and knowledge among middle-aged women.
    Leon-Leon P; Chedraui P; Hidalgo L; Ortiz F; Castelo-Branco C
    Gynecol Endocrinol; 2008 Oct; 24(10):580-5. PubMed ID: 19012102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perimenopausal knowledge of mid-life women in northern Taiwan.
    Tsao LI; Chang WY; Hung LL; Chang SH; Chou PC
    J Clin Nurs; 2004 Jul; 13(5):627-35. PubMed ID: 15189416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Understanding physicians' attitudes towards hormone therapy.
    Hess R; Chang CC; Conigliaro J; McNeil M
    Womens Health Issues; 2005; 15(1):31-8. PubMed ID: 15661585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Women's awareness and knowledge of hormone therapy post-Women's Health Initiative.
    Rigby AJ; Ma J; Stafford RS
    Menopause; 2007; 14(5):853-8. PubMed ID: 17429334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The dilemma of menopause and hormone replacement--a challenge for women and health-care providers: knowledge of menopause and hormone therapy in Spanish menopausal women.
    Castelo-Branco C; Peralta S; Ferrer J; Palacios S; Cornago S; Quereda F
    Climacteric; 2006 Oct; 9(5):380-7. PubMed ID: 17000585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current trends in hormone replacement therapy: perceptions and usage.
    Birkhäuser MH; Reinecke I
    Climacteric; 2008 Jun; 11(3):192-200. PubMed ID: 18568784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perceived barriers and recommendations concerning hormone replacement therapy counseling among primary care providers.
    Anderson LA; Caplan LS; Buist DS; Newton KM; Curry SJ; Scholes D; LaCroix AZ
    Menopause; 1999; 6(2):161-6. PubMed ID: 10374224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Scientific evidence changes prescribing practice--a comparison of the management of the climacteric and use of hormone replacement therapy among Swedish gynaecologists in 1996 and 2003.
    Thunell L; Milsom I; Schmidt J; Mattsson LA
    BJOG; 2006 Jan; 113(1):15-20. PubMed ID: 16398765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postmenopausal hormone therapy: who now takes it and do they differ from non-users?
    Taylor AW; MacLennan AH; Avery JC
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):128-35. PubMed ID: 16638035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attitudes and practices about postmenopausal hormone therapy among female gynecologists in Brazil.
    Filho AS; Soares Júnior JM; Arkader J; Maciel GA; Baracat EC
    Maturitas; 2005 Jun; 51(2):146-53. PubMed ID: 15917155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preferences for involvement in treatment decision-making generally and in hormone replacement and urinary incontinence treatment decision-making specifically.
    O'Donnell M; Hunskaar S
    Patient Educ Couns; 2007 Nov; 68(3):243-51. PubMed ID: 17904327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of hormone replacement therapy by menopausal women in six family-practice teaching clinics in Israel.
    Vinker S; Kaplan B; Yaphe J; Cohen O; Shumla V; Shapira G; Shofty I; Kitai E
    Climacteric; 2003 Mar; 6(1):75-80. PubMed ID: 12725667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hormone replacement therapy: women's decision-making process.
    Jones JB
    Soc Work Health Care; 1999; 28(3):95-111. PubMed ID: 10457983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Motives for initiation, temporary discontinuation, and permanent discontinuation of hormone replacement therapy use among Norwegian women.
    Øren A
    Maturitas; 2009 Sep; 64(1):33-7. PubMed ID: 19720480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hormone replacement therapy in postmenopausal women: utilization of health care resources by new users.
    Thorp JM; Gavin NI; Ohsfeldt RL
    Am J Obstet Gynecol; 2001 Aug; 185(2):318-26. PubMed ID: 11518885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spanish post-menopausal women's viewpoints on hormone therapy.
    Castelo-Branco C; Ferrer J; Palacios S; Cornago S; Peralta S
    Maturitas; 2007 Apr; 56(4):420-8. PubMed ID: 17174045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trends of determinants of hormone therapy use in Italian women attending menopause clinics, 1997-2003.
    Parazzini F;
    Menopause; 2008; 15(1):164-70. PubMed ID: 17581495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The declining impact of race and insurance status on hormone replacement therapy.
    Stafford RS; Saglam D; Causino N; Blumenthal D
    Menopause; 1998; 5(3):140-4. PubMed ID: 9774758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.